Skip to main content

GOLDMAN SACHS GROUP INC

Position in GRAL — GRAIL, Inc.

CIK 886982 NEW YORK, NY

Position in GRAL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$30,073,832
-$15,886,798 QoQ
Shares Held
581,924
+8.4% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 99.96820890700504.ToString("F0")% Shared 0.ToString("F0")% None 0.031791092994961544.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Dec 31, 2025
CallValue
$410,832
CallShares
4,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. GRAL ranks #23 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,073,832 581,924
2025-12-31 $45,960,630 536,986
2025-12-31 $410,832 4,800
2025-09-30 $21,584,341 365,032
2025-06-30 $3,727,898 72,499
2025-03-31 $662,226 25,929
2024-12-31 $758,517 42,494
2024-09-30 $658,401 47,849